Influence of “Probiotics + quadruple therapy” on the differentiation of Th subsets in gastric mucosa of patients with Helicobacter pylori-associated gastritis

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100043394

Enrollment

Unknown

Registered

2021-02-13

Start date

2021-03-01

Completion date

Unknown

Last updated

2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hp related gastritis

Interventions

experimental group:Probiotics + quadruple therapy

control group:quadruple therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.The 13 C UBT showed H.p infection in all cases. 2.Gastroscopy suggests chronic gastritis.

Exclusion criteria

Exclusion criteria: history of gastrectomy, peptic ulcer or other upper gastrointestinal lesions, gastrointestinal malignant tumor, contraindication or previous allergic reactions to the study drugs, severe concurrent diseases or malignancy, pregnant or lactating women.

Design outcomes

Primary

Measure	Time frame
Expression spectrum of Th subgroup related factors in gastric mucosa;Digestive symptoms;	—

Countries

China

Contacts

Public ContactXie Zhao-Lan

Wuhan Wuchang Hospital affiliated to Wuhan University of Science and Technology

xzl1954@163.com+86 15337204495

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026